BRWM
PTCT icon

B. Riley Wealth Management’s PTC Therapeutics PTCT Stock Holding History

B. Riley Wealth Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-100
Closed -$5K – 1084
2014
Q4 		$5K Buy
+100
New +$4.4K ﹤0.01% 852

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

B. Riley Wealth Management's PTCT Position: Q1 2015 in Review

B. Riley Wealth Management sold out of PTC Therapeutics (PTCT) in Q1 2015, closing a stake of 100 shares — an estimated $5K sold.

B. Riley Wealth Management first reported a position in PTCT in Q4 2014 and held it in 1 quarter. The position peaked at $5K in Q4 2014. 157 funds tracked by Wall St. Rank hold PTCT as of Q1 2015.

  • B. Riley Wealth Management reported no remaining PTC Therapeutics position as of Q1 2015 after selling out during the quarter.
  • B. Riley Wealth Management sold 100 PTC Therapeutics shares in Q1 2015, an estimated $5K.
  • B. Riley Wealth Management first reported a position in PTC Therapeutics in Q4 2014 and held it in 1 quarter.
  • B. Riley Wealth Management's PTC Therapeutics position peaked at $5K in Q4 2014.
  • 157 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2015.

Based on B. Riley Wealth Management's 13F filing for Q1 2015, filed 13 Apr 2015.